Literature DB >> 19386369

The expression pattern of TIR8 is conserved among vertebrates.

Federica Riva1, Nadia Polentarutti, Giulia Tribbioli, Alberto Mantovani, Cecilia Garlanda, Lauretta Turin.   

Abstract

IL-1R/TLRs play an important role in the inflammatory responses. Their signaling pathway is tightly regulated to keep inflammation under control. The regulation involves both extracellular and intracellular mechanisms. TIR8, also known as SIGIRR (Single Immunoglobulin IL-1R-Related molecule), is an orphan receptor belonging to the IL-1R/TLRs super-family. Recent studies suggest its role in modulating the inflammatory response in the gastrointestinal tract in mice, acting as an IL-1 receptor family antagonist. We identified the sequence and analyzed the expression of TIR8 in a wide panel of organs and tissues in different animals. There was high homology of the cDNA sequence among human, mouse and the domestic species (74-85%). The pattern of expression of this receptor was similar in all the species examined (high levels in kidney and gastrointestinal tract) and similar to the human. These results demonstrate that TIR8 is conserved, in evolutionary terms, both with regard to sequence and pattern of expression, a finding consistent with a key function of this molecule in modulating inflammation in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386369     DOI: 10.1016/j.vetimm.2009.03.009

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  10 in total

1.  The toll interleukin-1 receptor (IL-1R) 8/single Ig domain IL-1R-related molecule modulates the renal response to bacterial infection.

Authors:  Jaklien C Leemans; Loes M Butter; Gwendoline J D Teske; Ingrid Stroo; Wilco P Pulskens; Sandrine Florquin
Journal:  Infect Immun       Date:  2012-08-13       Impact factor: 3.441

2.  SIGIRR, a negative regulator of colon tumorigenesis.

Authors:  Junjie Zhao; Jarod Zepp; Katarzyna Bulek; Xiaoxia Li
Journal:  Drug Discov Today Dis Mech       Date:  2012-03-15

3.  IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy.

Authors:  Federica Riva; Laura Bianchessi; Camilla Recordati; Alessia Inglesi; Vittoria Castiglioni; Lauretta Turin
Journal:  Vet Sci       Date:  2022-06-14

4.  IL-1R8 Downregulation and Concomitant TLR7 and TLR9 Upregulation Are Related to the Pathogenesis of Canine Diffuse Large B-Cell Lymphoma.

Authors:  Federica Riva; Joel Filipe; Antonella Fanelli; Laura Marconato; Alessia Inglesi; Eugenio Scanziani; Sabina Soldati; Luca Licenziato; Stefano Comazzi; Lucia Minoli; Luca Aresu
Journal:  Vet Sci       Date:  2022-04-25

Review 5.  The chicken IL-1 family: evolution in the context of the studied vertebrate lineage.

Authors:  Mark S Gibson; Pete Kaiser; Mark Fife
Journal:  Immunogenetics       Date:  2014-05-27       Impact factor: 2.846

6.  Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation.

Authors:  Raffaella Bonecchi; Cecilia Garlanda; Alberto Mantovani; Federica Riva
Journal:  Cytokine       Date:  2016-08-04       Impact factor: 3.861

7.  TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity.

Authors:  Federica Riva; Eduardo Bonavita; Elisa Barbati; Marta Muzio; Alberto Mantovani; Cecilia Garlanda
Journal:  Front Immunol       Date:  2012-10-29       Impact factor: 7.561

8.  Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.

Authors:  Cecilia Garlanda; Federica Riva; Eduardo Bonavita; Stefania Gentile; Alberto Mantovani
Journal:  Front Immunol       Date:  2013-07-09       Impact factor: 7.561

Review 9.  Regulatory Role of IL-1R8 in Immunity and Disease.

Authors:  Martina Molgora; Isabella Barajon; Alberto Mantovani; Cecilia Garlanda
Journal:  Front Immunol       Date:  2016-04-20       Impact factor: 7.561

Review 10.  Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.

Authors:  Martina Molgora; Domenico Supino; Alberto Mantovani; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.